Urine-to-Serum Osmolality Ratio as a Prognostic Marker in Traumatic Brain Injury
Diagnostics · 02.04.2026 · 16 (7) · 1071
DOI: 10.3390/diagnostics16071071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 02.04.2026. Verfasst von Eun Young Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul 06351, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Prognostication in traumatic brain injury (TBI) remains challenging. The urine-to-serum osmolality (U/S) ratio may reflect hypothalamic–pituitary axis integrity, a critical but underexplored prognostic domain. We investigated whether the U/S ratio provides early prognostic value and enhances prediction when combined with conventional severity markers.
Methods
This retrospective study included 128 adult TBI patients admitted to a neurosurgical intensive care unit (ICU) with simultaneous osmolality measurements within 6 h of admission. The primary outcome was ICU mortality; the secondary outcome was poor neurological outcomes (Glasgow Outcome Scale 1–3).
Results
ICU mortality was 14.1% (18/128), and poor neurological outcome occurred in 41.8% (46/110). Non-survivors had significantly lower U/S ratios than survivors (1.09 ± 0.58 vs. 1.70 ± 0.68, p < 0.001). For ICU mortality, U/S ratios (AUC = 0.803) showed similar discriminative ability to GCS (AUC = 0.806). For poor neurological outcomes, the U/S ratio (AUC = 0.768) significantly outperformed both GCS (AUC = 0.641, p = 0.038) and the Acute Physiology and Chronic Health Evaluation (APACHE) II score (AUC = 0.553, p < 0.001). Combining the U/S ratio with GCS improved mortality prediction (AUC = 0.890), as did combinations with the APACHE II score (AUC = 0.847). The U/S ratio remained independently associated with ICU mortality and poor neurological outcomes after adjusting for GCS or APACHE II scores. Quartile analyses revealed a dose–response relationship, with ICU mortality of 34.4% in Q1 versus 3.1% in Q4 (p for trend < 0.001). Prognostic value was preserved in patients receiving osmotic therapy (n = 86).
Conclusions
The U/S ratio is a simple, readily available biomarker that independently predicts mortality and poor neurological outcomes in TBI patients. Particularly for neurological outcome predictions, it outperforms GCS or the APACHE II score alone. Combined with established severity scores, it may serve as a practical bedside tool reflecting hypothalamic–pituitary function in neurocritical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul 06351, Republic of Korea.
- Department of Neurosurgery, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul 06351, Republic of Korea.
ORCID-Profile: Jeong-Am Ryu
Zitieren
APA
Kim, E. Y., & Ryu, J. A. (2026). Urine-to-Serum Osmolality Ratio as a Prognostic Marker in Traumatic Brain Injury. Diagnostics, 16(7), 1071. https://doi.org/10.3390/diagnostics16071071
Vancouver
Kim EY, Ryu JA. Urine-to-Serum Osmolality Ratio as a Prognostic Marker in Traumatic Brain Injury. Diagnostics. 2026;16(7):1071. doi:10.3390/diagnostics16071071
BibTeX
@article{Kim2026,
author = {Kim, Eun Young and Ryu, Jeong-Am},
title = {Urine-to-Serum Osmolality Ratio as a Prognostic Marker in Traumatic Brain Injury},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {7},
pages = {1071},
doi = {10.3390/diagnostics16071071}
}
EUVIMED